Archive for November, 2009

Mesothelioma stages and staging system : Part – 4

Friday, November 27th, 2009

Brigham Staging System

It is the most recent staging system for mesothelioma and looks at variables such as lymph node status and tumor resectability (ability to surgically remove a tumor). The Brigham staging system consists of four stages:

Stage

Location

I

Resectable mesothelioma and no lymph node involvement

II

Resectable mesothelioma but with lymph node involvement

III

Unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph node involvement

IV

Distant metastatic disease

Mesothelioma stages and staging system : Part – 3

Thursday, November 26th, 2009

TNM Staging System

This system considers three components; the first letter of each forming the name of the system. Doctors using TNM will look at the tumor, lymph nodes, and whether the cancer has metastasized. Like the Butchart system, it is divided into four stages.

Stage

Location

T1a

Limited to ipsilateral parietal pleura (including mediastinal and diaphragmatic pleura), with no involvement of visceral pleura

T1b

Ipsilateral parietal pleura (including mediastinal and diaphragmatic pleura), with scattered foci of visceral pleural involvement

T2

Ipsilateral pleural surface has at least 1 of the following:

  • Diaphragmatic muscle involvement
  • Confluent visceral pleural tumor involvement (including fissures)
  • Extension from visceral pleura into pulmonary parenchyma

T3

Locally advanced but resectable tumor; each ipsilateral pleural surface has at least 1 of the following:

  • Involvement of the endothoracic fascia
  • Extension into the mediastinal fat
  • Solitary, completely resectable tumor focus in chest wall soft tissues
  • Nontransmural involvement of the pericardium

T4

Locally advanced, technically unresectable tumor; each ipsilateral pleural surface has at least 1 of the following:

  • Diffuse extension or multifocal chest wall masses with or without rib destruction
  • Direct transdiaphragmatic extension into the peritoneum
  • Direct extension to contralateral pleura
  • Direct extension to 1 or more mediastinal organs
  • Direct extension into spine
  • Extension through to internal surface of pericardium, with or without pericardial effusion or myocardial involvement

NX

Regional lymph nodes not assessable

N0

No regional lymph nodes metastases

N1

Metastases in ipsilateral bronchopulmonary or hilar lymph nodes

N2

Metastases in subcarinal or ipsilateral mediastinal lymph nodes, including ipsilateral internal mammary nodes

N3

Metastases in contralateral mediastinal, contralateral internal mammary, and ipsilateral or contralateral supraclavicular lymph nodes

MX

Distant metastases not assessable

M0

No distant metastases

M1

Distant metastases present

Mesothelioma stages and staging system : Part – 2

Wednesday, November 25th, 2009

An important aspect is that as pleural mesothelioma is the most common among all types of cancer and occurs frequently, these staging systems are devised to mark its stages.

The three established and recognized clinical staging systems for mesothelioma are:

  • The Butchart System
  • TNM Staging
  • The Brigham System

The Butchart Staging System:

Butchart is the oldest system and is still the most commonly used.  Its four stages are based on the extent of primary tumor mass.

Stage

Location

I

Tumor confined to the ipsilateral pleura, lung, or pericardium

II

Tumor invading the chest wall or mediastinal structures or metastases to thoracic lymph nodes

III

Tumor penetrating the diaphragm to involve the peritoneum or metastases to extrathoracic lymph nodes

IV

Distant blood-borne metastases

Mesothelioma stages and staging system : Part – 1

Friday, November 20th, 2009

Staging is the process of finding out how far the mesothelioma cancer has spread. Doctors determine which treatments to use based on the mesothelioma stage, or the severity of the disease. Staging of mesothelioma is based on imaging studies such as x-rays, CT scans, and MRI scans.

To keep a track of mesothelioma cancer, the extent of its spread and the size of tumor(s); mesothelioma has been divided into a few stages or staging systems. These mesothelioma staging systems keep a track of the development of cancer in the human body. The tests and scans when diagnosing cancer give some information about the stage. It is important because treatment is often decided according to the stage of a cancer.
Some elements common to most staging systems are:
• Location of the primary tumor.
• Size and number of the tumors.
• Lymph node involvement.
• Cell type and tumor grade.
• Metastasis.

Many cancer registries, such as the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (SEER) use summary staging, a system used for all types of cancer. Summary staging groups cancer into five main categories:

• In situ – cancer that is present only in the layer of cells in which it began.

• Localized – cancer that is limited to the organ in which it began with no evidence of spread.

• Regional – cancer that has spread from the primary site to nearby lymph nodes or organs.

• Distant – cancer that has spread from the primary site to distant lymph nodes or organs.

• Unknown – cases where not enough information exists to indicate stage.

Diagnosis of Mesothelioma: Part – 4

Thursday, November 19th, 2009

Biopsy:

If, after performing all above tests, a doctor suspects mesothelioma, a biopsy should be taken to confirm the mesothelioma diagnoses.

If tests and health history are consistent with mesothelioma, a biopsy allows the doctor to make a conclusive diagnosis. The biopsy is an effective diagnostic tool, but is not used first because the removal of sample of cells or tissue is more invasive than a simple X-ray or blood draw.

The most definitive test for diagnosing mesothelioma is a biopsy (tissue sample) of affected or suspicious tissues. In that doctor who specializes in diagnosing and treating cancer removes sample of tissue for microscopic examination by a pathologist. The pathologist usually also looks for the rate of growth and strength of the tumor.

Types of biopsies:

A biopsy may be done in different ways, depending on where the abnormal area is located.

Fine-needle aspiration biopsy: The physician uses a thin needle to remove a sample of possibly-diseased cells.

Thoracotomy: In this an incision or small cut is made by physician between two ribs to check inside for signs of disease and to collect a tissue sample.

Thoracoscopy: If the cancer is in the chest, the doctor may perform a thoracoscopy. In this procedure the incision is made by physician between two ribs and inserts a thin, lighted tube into the chest called a thoroscope. The tube contains a tool to collect cells for examination under a microscope. This test is usually done in a hospital using a local anesthetic or painkiller. If fluid has found in the chest, doctor may drain the fluid out of the body by putting a needle into the chest and using gentle suction to remove the fluid. This is called thoracentesis.

Peritoneoscopy and laparotomy: If the cancer is found in the abdomen, the doctor may perform peritoneoscopy and laproscopy. These procedures are similar to the thoracoscopy, but the incision is made in the abdominal wall. A thin, lighted tube is used to examine inside the abdomen is called a peritoneoscope. The peritoneoscope is put into an opening made in the abdomen and to collect cells for examination under a microscope. Before the test is done, a local anesthetic will be given. If fluid has collected in your abdomen, your doctor may drain the fluid out of your body by putting a needle into your abdomen and using gentle suction to remove the fluid. This process is called paracentesis.

After the sample has been removed, it will be sent to a pathologist, a physician who specializes in cancer and its diagnosis. This doctor will examine the cells under a microscope to check for any abnormalities that might indicate cancer. In some cases, the first biopsy will remove fluid from around the lungs or from the abdomen. The pathologist will examine the cells found in this fluid for signs of cancer; however, many physicians consider this test insufficient for mesothelioma diagnosis.

Diagnosis of Mesothelioma: Part – 3

Wednesday, November 18th, 2009

X-rays:

Chest or abdomen x-rays can reveal fluid build-up, masses in the chest, or signs of non-cancerous pleural disease, scarring of the lungs and areas of fluid accumulation. Based on a patient’s x-ray results, a doctor will usually order more sensitive tests.

Computerized Tomography (CT) scans:

A CT scan is a series of detailed pictures of areas inside the body created by a computer linked to an x-ray machine. A computerized axial tomography (CAT or CT) scan produces a cross-sectional image of the parts of your body that your doctor wants to study, such as the chest and abdomen. An x-ray source rotates around your body sending data to a computer. A CAT scan helps your doctor determine how large any tumors are, where they are in relation to the heart, lungs and diaphragm, if there is pleural thickening, and how much fluid there is. A CAT scan also helps your doctor determine what stage your cancer is in.

The computer then analyzes the data and produces a series of images. CT scans are also able to define pleural effusion, as well as pleural thickening, pleural calcification, thickening of interlobular fissures, or possible chest wall invasion. CT scans cannot differentiate between benign or malignant mesothelioma. CT scans may also be valuable in guiding fine needle aspiration of pleural masses for tissue diagnosis.

Positron Emission Tomography (PET) scans:

PET imaging tests have become one of the most efficient ways of diagnosing mesothelioma tumors as well as determining the staging of the cancer. In a positron emission tomography (PET) scan, abnormal areas show up as bright spots. These bright spots may or may not be cancer, so not all doctors believe that these scans are helpful in trying to diagnose mesothelioma cancer. If you have mesothelioma cancer, a PET scan can show whether the cancer has spread outside the area of the body in which it originated (whether it has metastasized).

While PET scans are more expensive than other types of imaging, and are not always covered under insurance, they are now considered to be the most diagnostic of tumor sites, as well as the most superior in determining the staging of mesothelioma.

MRI scans:

Magnetic resonance imaging (MRI) is a type of scan that uses a magnetic field linked to a computer to create an image of the internal structures of your body. An MRI uses powerful magnets and radio waves to produce a detailed, three-dimensional view of the areas where mesothelioma is suspected.

MRI scans use a computer-linked magnet to photograph details of the inside of the body and can determine the severity of a tumor. MRI scans are most often used to determine the extent of tumor prior to aggressive treatment. Because they provide images in multiple planes, they are better able to identify tumors as opposed to normal structures. Sometimes, an MRI can show whether a tumor has invaded the diaphragm or chest wall.

They are also more accurate than CT scans in assessing enlargement of the mediastinal lymph nodes (those lymph nodes which lie between the two lungs), as well as a clear diaphragmatic surface, both of which play an important role in surgical candidacy.